| Application no. and date | 17731411.9 (espacenet) (Federated) (European Patent Register), 20170608 | | Patent/reg. no. and date | DK/EP 3468997, 20230913 | | Publication date | 20190417 | | Priority no. and date | US 201662347419 P, 20160608, US 201662399896 P, 20160926, US 201662421261 P, 20161112 | | EP pub. no. and date |
EP 3468997 20190417 | | Effective date | | | Applicant/owner | Xencor, Inc., 465 North Halstead Street
Pasadena, CA 91107, US | | Applicant ref. no. | V464565DK00 | | Inventor | ZACK, Debra, 111 West Lemon Avenue
Monrovia, California 91016, US,
STONE, John H., 111 West Lemon Avenue
Monrovia, California 91016, US,
PILLAI, Shiv, 111 West Lemon Avenue
Monrovia, California 91016, US,
FOSTER, Paul, 111 West Lemon Avenue
Monrovia, California 91016, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 37/06 (2006.01) , C07K 16/28 (2006.01) | | Title | Behandling af IgG4-relaterede sygdomme med anti-CD9-antistoffer med tværbinding til CD32B | | Int. application no. | US2017036635 | | Int. publication no. | WO2017214452 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
